COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,547 Articles (22,881 medRxiv, 8,666 bioRxiv)

Most recent first Previous |  Page 2053: Articles 20521-20530  | Next

Epidemiological and Economic Impact of COVID-19 in the US
Chen, J., Vullikanti, A., Santos, J., Venkatramanan, S., Hoops, S., Mortveit, H., Lewis, B., You, W., Eubank, S., Marathe, M., Barrett, C., Marathe, A.
10.1101/2020.11.28.20239517 — Posted: 2020-11-30
Increased Prescribing of Psychotropic Medications to Ontario Nursing Home Residents during the COVID-19 Pandemic
Stall, N. M., Zipursky, J. S., Rangrej, J., Jones, A., Costa, A. P., Hillmer, M. P., Brown, K. A.
10.1101/2020.11.26.20239525 — Posted: 2020-11-30
Changes COVID-19 Post-Quarantine Behaviors, Hygiene and Expectations in Colombia: Population Survey from 1st to 13th September, 2020.
Sanchez, S. M., Rivera Montero, D. F., Murad Rivera, R., Calderon Jaramillo, M., Roldan Restrepo, D., Castano Mesa, L. M., Rivillas Garcia, J. C.
10.1101/2020.11.26.20239442 — Posted: 2020-11-30
Obesity as a predictor for adverse outcomes among COVID-19 patients: A meta-analysis
Das, P., Samad, N., Seidu, A.-A., Aboagye, R. G., Tetteh, J. K., Ahinkorah, B. O.
10.1101/2020.11.27.20239616 — Posted: 2020-11-30
Dietary supplements during the COVID-19 pandemic: insights from 1.4M users of the COVID Symptom Study app - a longitudinal app-based community survey
Louca, P., Murray, B., Klaser, K., Graham, M. S., Mazidi, M., Leeming, E. R., Thompson, E. J., Bowyer, R., Drew, D. A., Nguyen, L. A., Merino, J., Gomez, M. F., Mompeo, O., Costeira, R., Sudre, C. H., Gibson, R., Steves, C., Wolf, J., Franks, P. W., Ourselin, S., Chan, A. T., Berry, S. E., Valdes, A., Calder, P., Spector, T. D., Menni, C.
10.1101/2020.11.27.20239087 — Posted: 2020-11-30 Discussion: Onsite | Offsite
Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2
Huisman, J. S., Scire, J., Angst, D. C., Neher, R. A., Bonhoeffer, S., Stadler, T.
10.1101/2020.11.26.20239368 — Posted: 2020-11-30
Modelling the impact of health-related variables, age, migration, and socio-economic factors in the geographical distribution of early tested case-fatality risks associated with COVID-19 in Mexico
Ramirez-Aldana, R., Gomez-Verjan, J. C., Bello-Chavolla, O. Y., Garcia-Pena, C.
10.1101/2020.11.26.20239376 — Posted: 2020-11-30
Prevalence and stability of SARS CoV-2RNA on Bangladeshi banknotes
Akter, S., Roy, P. C., Ferdaus, A., Ibnat, H., Rubayet-Ul-Alam, A. S. M., Nigar, S., Jahid, I. K., Hossain, M. A.
10.1101/2020.11.26.20233627 — Posted: 2020-11-30
Quantifying superspreading for COVID-19 using Poisson mixture distributions
Kremer, C., Torneri, A., Boesmans, S., Meuwissen, H., Verdonschot, S., Vanden Driessche, K., Althaus, C. L., Faes, C., Hens, N.
10.1101/2020.11.27.20239657 — Posted: 2020-11-30
Predictors of QT Interval Prolongation in Critically-ill Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine
Scuotto, F., Marra, R., Almeida, L. L. d., Soares, M. S. R., Silva, G. K., Paul, L. C., Fenelon Costa, G. D., Cirenza, C.
10.1101/2020.11.26.20239418 — Posted: 2020-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).